This is not surprising because in the airways of patients with allergic asthma, the drug reduces FcεRI+ (IgE high affinity receptor) and IgE+ cells and causes a profound reduction in tissue eosinophilia, together with reductions in submucosal T-cell and B-cell counts [5,20]. The gene discussed is IGHE; the disease is allergic asthma.